Schizophrenia Research-Cognition is an esteemed journal dedicated to advancing the understanding of cognitive aspects of schizophrenia and related mental health disorders. Published by Elsevier, this Open Access journal has been a pivotal platform since its inception in 2014, facilitating the dissemination of high-quality research findings to a global audience. With a notable impact factor and categorized in the Q2 quartile for both Cognitive Neuroscience and Psychiatry and Mental Health, it ranks among the top journals in these fields, currently positioned at #171 out of 567 in Psychiatry and at #40 out of 115 in Cognitive Neuroscience according to Scopus metrics. Located in the United States, and published under the auspices of Elsevier, the journal aims to provide an insightful forum for researchers, clinicians, and students interested in the cognitive underpinnings of schizophrenia, promoting innovative research that bridges the gap between cognitive neuroscience and clinical application. Schizophrenia Research-Cognition's commitment to open access ensures wide-reaching impact and engagement from the research community and beyond.

Cognitive Neuropsychiatry is a distinguished academic journal published by Routledge Journals, Taylor & Francis Ltd, dedicated to the intersection of cognitive neuroscience and psychiatry. With a strong commitment to advancing knowledge in these rapidly evolving fields, this journal provides a platform for high-quality, peer-reviewed research that explores cognitive processes underlying psychiatric disorders. Aiming to bridge gaps between neuroscience and clinical practice, it serves as an essential resource for researchers, professionals, and students alike. As evidenced by its performance metrics, the journal ranks in the Q2 quartile for Psychiatry and Mental Health, and Q3 for Cognitive Neuroscience, showcasing its relevance and growing impact, particularly among a competitive audience. While it does not currently offer open access options, Cognitive Neuropsychiatry remains a vital outlet for disseminating impactful findings, offering insights that shape contemporary psychiatric understanding and interventions.

Heart and Mind, published by Wolters Kluwer Medknow Publications, is a distinguished open access journal that has been serving the fields of Cardiology, Clinical Psychology, Neurology, and Psychiatry since its inception in 2017. With an ISSN of 2468-6476 and an E-ISSN of 2468-6484, this journal aims to bridge the rapidly evolving intersection between cardiovascular health and mental well-being. Based in India, it has gained recognition reflected by its Category Quartiles standing in Q3 across multiple disciplines, demonstrating its relevance and contribution to ongoing research. Researchers, healthcare professionals, and students will find Heart and Mind a valuable resource, as it facilitates access to critical insights and innovative studies within these interconnected fields. The journal’s commitment to open access ensures that vital findings and advancements are available to a global audience, fostering collaboration and knowledge-sharing to advance healthcare practices. Emphasizing high-quality research, Heart and Mind continually strives to elevate the understanding of cardiovascular and mental health, making it a pivotal platform for contemporary academic discourse.

PSYCHOPHARMACOLOGY is a leading peer-reviewed journal specializing in the field of pharmacology, specifically focusing on the effects of drugs on behavior, cognition, and emotion. Published by Springer, this esteemed journal has established itself as a pivotal resource for researchers and professionals since its inception in 1959, maintaining its relevance and rigor in the ever-evolving landscape of psychopharmacological research. With an impressive impact factor and ranking in the top quartile (Q1) of the Pharmacology category in 2023, it consistently publishes high-quality studies that contribute to both academic inquiry and clinical practice. The journal's scope includes original research, theoretical papers, and reviews, fostering a multidisciplinary dialogue among psychologists, psychiatrists, pharmacologists, and neuroscientists. As the field of psychopharmacology continues to grow, PSYCHOPHARMACOLOGY remains dedicated to disseminating innovative findings, operationalizing complex concepts, and enhancing the understanding of drug mechanisms and their implications for mental health. This commitment to excellence positions PSYCHOPHARMACOLOGY as an indispensable tool for those seeking to advance their knowledge and research in pharmacology.

Current Behavioral Neuroscience Reports, published by SPRINGERNATURE, stands at the forefront of advancements in the intricate field of behavioral neuroscience. Since its inception in 2014, this journal has steadily garnered attention within academic circles, boasting a commendable ranking among its peers, including a Q3 classification in Behavioral Neuroscience and a Q2 classification in Public Health, Environmental and Occupational Health as of 2023. Although it operates under traditional access models, the journal is committed to disseminating high-quality research that bridges the gap between neuroscience and behavioral studies, appealing to researchers, professionals, and students alike. With a notable E-ISSN of 2196-2979, Current Behavioral Neuroscience Reports facilitates valuable insights that are critical for understanding the underlying mechanisms of behavior and their implications for public health and environmental factors. This journal is essential for those seeking to contribute to a multidisciplinary dialogue that enhances our comprehension of behavioral neuroscience.

Schizophrenia, published by NATURE PORTFOLIO, is a pioneering open-access journal established in 2022, dedicated to advancing the scientific understanding of schizophrenia and its associated disorders. With its commitment to disseminating high-quality research without barriers, this journal aims to provide a platform for innovative studies, reviews, and meta-analyses that enhance clinical practices and therapeutic approaches. The journal is strategically located in Berlin, Germany, a hub for mental health research and innovation. By facilitating open exchange among researchers, professionals, and students, Schizophrenia aspires to be at the forefront of the global discourse on psychiatric disorders, driving forward critical advancements that can translate into improved patient care and outcomes. With a focus on promoting the latest findings in epidemiology, neurobiology, pharmacology, and psychosocial interventions, this journal is poised to become an essential resource for scholars and practitioners alike, eager to make significant contributions to the field.

Cognitive Neurodynamics is a leading journal in the field of cognitive neuroscience, published by Springer in the Netherlands. With an ISSN of 1871-4080 and an E-ISSN of 1871-4099, this journal has established itself as a prominent platform for innovative research from its inception in 2007, continuing to enrich the academic landscape through 2024. Recognized for its significant contributions, Cognitive Neurodynamics holds a Q2 quartile ranking in cognitive neuroscience and impressively ranks #27 out of 115 in the Scopus database, placing it in the 76th percentile among its peers. While the journal is not open access, it offers a wealth of studies focusing on the intricate dynamics of cognitive processes and neurobiological mechanisms, making it essential reading for researchers, professionals, and students alike. Its objective is to bridge the gap between theoretical insights and practical applications, fostering a deeper understanding of cognition through multidisciplinary approaches. Explore the latest advancements in cognitive dynamics and contribute to the evolving dialogue within this fascinating field.

Brain and Behavior is a premier open-access journal published by WILEY, dedicated to advancing the field of Behavioral Neuroscience. With its ISSN 2162-3279, the journal has established itself as a vital resource for researchers, professionals, and students alike, fostering the dissemination of cutting-edge research since its inception in 2011. Renowned for its rigorous peer-review process, it enjoys a commendable Q2 ranking within the field, reflecting its impactful contributions and relevance in the scientific community. The journal not only emphasizes innovative studies that bridge behavioral science and neuroscience but also serves as a platform for diverse methodologies and interdisciplinary approaches. Accessible [open access](https://onlinelibrary.wiley.com/journal/21623279), Brain and Behavior invites submissions that explore the neural mechanisms underlying behavior, aiming to engage a global audience eager to expand the boundaries of knowledge in this dynamic field. Positioned in the heart of the United States, at 111 River St, Hoboken, NJ, it is strategically placed to collaborate with leading institutions and researchers worldwide.

Frontiers in Psychiatry is a leading journal dedicated to advancing research within the field of psychiatry and mental health. Published by FRONTIERS MEDIA SA, the journal has established a commendable reputation since its inception, reflected in its Q1 status in the 2023 Psychiatry and Mental Health category and a robust ranking of 142 out of 567 in the Scopus database. With an open access model initiated in 2009, Frontiers in Psychiatry aims to disseminate high-quality research to a global audience, fostering collaboration and innovation among researchers, clinicians, and students alike. The journal covers a broad spectrum of topics, including neurobiology, psychosocial factors, treatments, and public health implications of mental disorders, ensuring comprehensive representation of contemporary psychiatric science. Located in Lausanne, Switzerland, and running until 2024, the journal not only emphasizes the importance of mental health research but also encourages interdisciplinary discourse, making it an essential resource for anyone invested in the well-being of individuals and communities alike.

Biological Psychiatry-Cognitive Neuroscience and Neuroimaging is a leading interdisciplinary journal published by Elsevier, focusing on the convergence of biological psychiatry, cognitive neuroscience, and advanced neuroimaging techniques. With its prestigious Q1 rankings across essential categories such as Biological Psychiatry, Cognitive Neuroscience, and Neurology (clinical), this journal is at the forefront of research that examines the complexities of mental health through innovative methodologies. Covering a broad spectrum of topics from neurobiological mechanisms to clinical applications, it aims to provide a platform for scholars and practitioners to exchange insights on mental disorders and their neurobiological underpinnings. The impact factor and Scopus rankings further underscore its importance, with rankings highlighting its position in the top percentiles of related disciplines. By fostering an open exchange of ideas and promoting cutting-edge research, this journal is an essential resource for researchers, professionals, and students dedicated to advancements in the understanding and treatment of psychiatric and neurological conditions.